Standardized Weaning from Temporary Extracorporeal Life Support in Cardiovascular Patients.
Aged
Cardiovascular Diseases
/ diagnosis
Clinical Decision-Making
Databases, Factual
Extracorporeal Membrane Oxygenation
/ adverse effects
Female
Humans
Male
Middle Aged
Outcome and Process Assessment, Health Care
/ standards
Practice Guidelines as Topic
/ standards
Recovery of Function
Retrospective Studies
Time Factors
Treatment Outcome
Journal
The Thoracic and cardiovascular surgeon
ISSN: 1439-1902
Titre abrégé: Thorac Cardiovasc Surg
Pays: Germany
ID NLM: 7903387
Informations de publication
Date de publication:
08 2020
08 2020
Historique:
pubmed:
18
6
2019
medline:
15
12
2020
entrez:
18
6
2019
Statut:
ppublish
Résumé
Separation from extracorporeal life support (ECLS) is often based on individual decisions rather than evaluated standard operating procedures (SOPs). Therefore, we strived to evaluate a SOP, summarizing specific treatment paths for this group of patients. A total of 107 cardiovascular patients were supported with ECLS within a 4-year period. Fifty-three patients were treated before the SOP was introduced (group A) and 54 patients were treated afterward (group B). Patient characteristics and outcomes were analyzed and compared between the two time periods regarding baseline characteristics, compliance with SOP criteria, and the end points successful weaning and 30-day survival. Successful weaning rose significantly from 56.6 to 74.1% ( The SOP for ECLS weaning showed higher weaning rates compared with a weaning based on individual decisions. Although only parts of the SOP were associated with higher weaning and survival rates, the SOP was experienced as a useful guideline for standardized ECLS management.
Identifiants
pubmed: 31207648
doi: 10.1055/s-0039-1692177
doi:
Types de publication
Journal Article
Observational Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
425-432Informations de copyright
Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
Dr. Trummer reports personal fees from Resuscitec GmbH, outside the submitted work. All other authors have no conflict of interest.